AstraZeneca (AZNCF)

AI Score

Unlock

132.38

-7.42 (-5.31%)

At close: Apr 21, 2025, 3:52 PM

AstraZeneca Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	54.04B	51.49B	49.42B	47.87B	46.12B	44.99B	44.48B	43.84B	44.35B	45.15B	44.04B	41.49B	37.42B	32.82B	29.53B	27.58B	26.62B	25.87B	25.7B	25.25B	24.38B	24.14B	23.07B	22.4B	22.09B	21.45B	22.34B	22.24B	22.46B	22.27B	21.74B	22.29B	23B	23.82B	24.06B	24.77B
Cost of Revenue	12.09B	12.74B	11.76B	10.56B	9.34B	8.86B	9.75B	10.79B	12.39B	14.12B	14.89B	14.08B	12.44B	9.34B	6.95B	5.74B	5.3B	5.15B	5.13B	5.21B	4.92B	5.18B	4.98B	4.93B	4.94B	4.52B	4.62B	4.56B	4.32B	4.25B	3.9B	4.02B	4.13B	4.24B	4.38B	4.38B
Gross Profit	41.96B	38.75B	37.66B	37.3B	36.78B	36.13B	34.74B	33.05B	31.96B	31.04B	29.15B	27.4B	24.98B	23.48B	22.58B	21.84B	21.32B	20.72B	20.57B	20.04B	19.46B	18.96B	18.09B	17.47B	17.15B	16.93B	17.72B	17.68B	18.15B	18.02B	17.84B	18.28B	18.88B	19.58B	19.69B	20.39B
Operating Income	10.22B	9.5B	9.35B	8.96B	8.28B	8.05B	7.34B	5.43B	3.76B	2.37B	-549M	39M	1.06B	2.83B	5.68B	5.84B	5.16B	4.25B	3.84B	3.05B	2.92B	3.42B	3.52B	3.79B	3.39B	3B	3.29B	3.46B	3.68B	5.52B	5.4B	4.78B	4.9B	3.46B	3.6B	4.22B
Interest Income	458M	504.82M	422.82M	386.82M	353.82M	288M	202M	156M	95M	51M	51M	40M	43M	49M	41M	56M	87M	119M	149M	168M	172M	159M	156M	158M	138M	161M	159M	144M	127M	101M	82M	71M	67M	57M	53M	49M
Pretax Income	8.69B	7.95B	7.77B	7.46B	6.92B	6.78B	6.05B	4.21B	2.5B	1.09B	-1.84B	-1.32B	-265M	1.54B	4.39B	4.59B	3.92B	2.99B	2.54B	1.73B	1.55B	2.04B	2.11B	2.38B	1.99B	1.67B	1.94B	2.02B	2.23B	4B	3.93B	3.41B	3.55B	2.17B	2.43B	3.11B
Net Income	7.04B	6.5B	6.44B	6.33B	5.96B	5.9B	6.16B	4.7B	3.29B	2.04B	-1.25B	-1.06B	112M	1.47B	3.77B	3.98B	3.2B	2.5B	2.15B	1.52B	1.33B	2.06B	2.19B	2.41B	2.15B	2.42B	2.68B	2.8B	3B	3.54B	3.87B	3.39B	3.5B	2.46B	2.22B	2.92B
Selling & General & Admin	19.48B	18.57B	18.21B	18.27B	18.89B	19.02B	17.37B	17.07B	17.84B	18.3B	18B	16.39B	14.46B	12.53B	11.82B	11.36B	11.13B	10.91B	11.89B	12.17B	11.96B	11.56B	10.8B	10.42B	10.36B	10.83B	10.91B	10.7B	10.54B	8.85B	8.76B	9.47B	9.74B	11.04B	11.32B	11.22B
Research & Development	13.49B	11.8B	11.27B	10.93B	10.85B	10.49B	10.26B	10.14B	9.66B	9.62B	9.41B	8.7B	8.28B	7.41B	6.71B	6.27B	5.95B	6.3B	6.18B	6.14B	6.02B	5.96B	5.91B	5.92B	5.93B	5.47B	5.6B	5.58B	5.76B	5.75B	5.75B	5.86B	5.89B	6.09B	6.12B	6.12B
Other Expenses	-128M	-28M	-3M	0.03	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1M	1M	1M	1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	32.78B	30.29B	29.35B	28.35B	28.75B	28.32B	27.47B	27.7B	28.04B	28.5B	29.35B	27.02B	23.58B	20.3B	16.75B	15.85B	16B	16.27B	16.63B	16.89B	16.44B	15.48B	14.57B	13.68B	13.77B	13.93B	14.43B	14.22B	14.47B	12.5B	12.43B	13.49B	13.97B	16.12B	16.09B	16.17B
Interest Expense	1.74B	1.77B	1.7B	1.69B	1.64B	1.55B	1.5B	1.38B	1.35B	1.32B	1.32B	1.33B	1.3B	1.28B	1.27B	1.28B	1.31B	1.34B	1.36B	1.4B	1.43B	1.42B	1.43B	1.44B	1.42B	1.4B	1.45B	1.52B	1.52B	1.57B	1.5B	1.4B	1.38B	1.31B	1.21B	1.14B
Selling & Marketing Expenses	555M	18.24B	23.02B	28.01B	32.07B	19.02B	17.37B	17.07B	17.84B	18.3B	18B	16.39B	14.46B	12.53B	11.82B	11.36B	11.13B	10.91B	11.89B	12.17B	11.96B	11.56B	10.8B	10.42B	10.36B	10.83B	10.91B	10.7B	10.54B	8.85B	8.76B	9.47B	9.74B	11.04B	11.32B	11.22B
Cost & Expenses	43.9B	42.06B	40.14B	38.91B	38.09B	37.18B	37.22B	38.49B	40.43B	42.62B	44.24B	41.1B	36.02B	29.64B	23.7B	21.59B	21.3B	21.42B	21.76B	22.1B	21.36B	20.66B	19.55B	18.61B	18.7B	18.45B	19.05B	18.78B	18.79B	16.75B	16.34B	17.51B	18.1B	20.36B	20.46B	20.55B
Income Tax Expense	1.65B	1.42B	1.3B	1.1B	936.38M	876M	-118M	-499M	-792M	-958M	-588M	-261M	-380M	72M	624M	633M	772M	573M	500M	311M	321M	79M	21M	80M	-57M	-632M	-606M	-653M	-641M	579M	163M	118M	146M	-226M	254M	215M
Shares Outstanding (Basic)	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.5B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.26B	1.26B	1.26B	1.26B	1.26B
Shares Outstanding (Diluted)	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.55B	1.5B	1.32B	1.32B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.27B	1.26B	1.26B
EPS (Basic)	4.53	4.20	4.13	4.08	3.86	3.82	4.03	3.07	2.14	1.32	-0.84	-0.65	0.29	1.29	2.88	3.04	2.44	1.90	1.64	1.15	1.03	1.61	1.72	1.90	1.70	1.91	2.11	2.22	2.37	2.80	3.06	2.68	2.77	1.94	1.75	2.30
EPS (Diluted)	4.50	4.17	4.11	4.05	3.83	3.80	4.00	3.05	2.13	1.31	-0.84	-0.65	0.28	1.28	2.87	3.03	2.44	1.90	1.64	1.15	1.03	1.61	1.72	1.90	1.70	1.91	2.11	2.22	2.37	2.79	3.05	2.67	2.76	1.94	1.74	2.29
EBITDA	17.11B	15.36B	14.48B	14.21B	13.63B	13.33B	12.58B	10.58B	8.85B	8.38B	7.03B	7.03B	7.58B	7.93B	8.8B	8.94B	8.34B	8.29B	7.79B	7B	6.67B	7.14B	7.3B	7.62B	7.35B	6.35B	6.67B	6.85B	7.24B	8.11B	8.05B	7.52B	7.39B	6.62B	6.69B	7.37B
EBIT	10.43B	9.64B	9.34B	8.95B	8.37B	8.19B	7.45B	5.53B	3.78B	2.37B	-542.38M	38.75M	1.07B	2.82B	5.66B	5.82B	5.13B	4.24B	3.83B	3.04B	2.95B	3.4B	3.48B	3.77B	3.36B	2.91B	3.24B	3.39B	3.59B	5.55B	5.42B	4.79B	4.92B	3.45B	3.6B	4.22B
Depreciation & Amortization	6.68B	5.71B	5.13B	5.14B	5.42B	5.58B	5.61B	5.63B	5.39B	6.06B	7.52B	6.95B	6.47B	5.06B	3.14B	3.11B	3.15B	4B	3.91B	3.93B	3.76B	3.78B	3.76B	3.72B	3.75B	3.2B	3.15B	3.09B	3.04B	2.52B	2.48B	2.45B	2.36B	2.48B	2.44B	2.57B